FOMDWebPartPage

2014 Publications

1.      Halloran PF, Reeve J, Pereira AB, Hidalgo LG, Famulski KF. Antibody-mediated rejection, T cell–mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies. Kidney Int 2014;(85):258-64.

2.      Wang, Z, Famulski K, Lee J, Das SK, Wang X, Halloran PF, Oudit GY, Kassirri Z. TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury. Kidney Int 2014;(85):82:93.

3.      Loupy A, Lefaucheur C, Vernerey D, Chang J, Hidalgo LG, Beuscart T, et al. Molecular Microscope Strategy to Improve Risk Stratification​ in Early Antibody-Mediated Kidney Allograft Rejection. J Am Soc Nephrol 2014;(25):2267-2277.

4.      Kreepala C, Famulski KS, Halloran PF. Fundamental Concepts Regarding Graft Injury and Regeneration: Tissue Injury, Tissue Quality and Recipient Factors. In: Kirk AD, Knechtle SJ, Larsen CP, Madsen JC, Pearson TC, Webber SA, editors. Textbook of Organ Transplantation. 1st ed.  John Wiley & Sons, Ltd.; 2014. p. 99-118.

5.      Venner JM, Famulski K, Badr D, Hidalgo LG, Chang J, Halloran PF. Molecular landscape of T cell-mediated rejection in human kidney transplants: Prominence of CTLA4 and PD ligands. Am J Transplant 2014;(11):2565-2576.

6.      Halloran BP, Chang J, Shi DQ, McGovern D, Famulski K, Evaschesen C, et al. Molecular patterns in human ulcerative colitis and correlation with response to infliximab. Inflamm Bowel Dis 2014;(12):2253-63.